Page 1

● WELL Health Achieves Record Financial Results with Over $ 99M Quarterly Revenue and Over $ 22M Adjusted EBITDA in Q3-2021 WELL reported record quarterly revenues of $ 99.3 million in Q3-2021 reflecting a 711 % year - over - year ( YoY ) increase compared to Q3-2020 . WELL's growth was primarily driven by the acquisitions of CRH Medical Corporation ( “ CRH " ) and MyHealth Partners Inc. ( " MyHealth " ) , along with a 597 % YoY increase in the Company's Virtual Services revenue ( 3 ) in the quarter . WELL achieved Adjusted EBITDA ( 2 ) of $ 22.3 million in Q3-2021 , compared to Adjusted EBITDA ( 2 ) loss of $ 0.2 million for Q3-2020 . WELL expects to end the calendar year with proforma annualized revenue run - rate approaching $ 450 million and Adjusted EBITDA ( 2 ) run - rate approaching $ 100 million . WELL delivered 582,958 total omni - channel patient visits in Q3-2021 , representing a YOY increase of 139 % . Vancouver , B.C. - November 10 , 2021 - WELL Health Technologies Corp. ( TSX : WELL ) ( the " Company " or " WELL " ) , a company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally , announced today its results for the third quarter of 2021 ended September 30 , 2021 . Hamed Shahbazi , Chairman and CEO of WELL commented , " We had an outstanding quarter mainly as a result of the growing success of our practitioner enablement platform and strong financial performance from our recent acquisitions . In the third quarter we also achieved adjusted gross profit ( ¹ ) of $ 50.0 million which was almost 10 times the adjusted gross profit as compared to the same period last year . Our adjusted gross margin ( 1 ) percentage increased to over 50 % for the first time , and we have now accomplished four consecutive quarters of positive Adjusted EBITDA ( 2 ) , which has experienced significant growth throughout the year . " Mr. Shahbazi added , " We could not have achieved such stellar results if it wasn't for the healthcare practitioners and clinicians that provide outstanding care every day as well as all the clinical , IT and corporate staff that support them every day . Our outlook is strong and resilient with 93 % of our revenues being recurring or highly re - occurring . We are looking forward to delivering continued strong results in the next few quarters , with sustained organic growth from both key lines of business . "